Biomerica Share Price

Biomerica Share Price

NASDAQ: BMRA | Micro Cap | Healthcare
$1.09
+$1.09 (--%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Biomerica Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$1.08 - $2.86
Volume
N/A
Average Traded
N/A

Biomerica Share Price Chart

Line chart of the Biomerica price trend over the selected period. The price rose overall, ranging from 1.08 to 1.09, ending at 1.09.
$0.00$0.00
L
Show Current Price
H

Biomerica Stock Fundamentals & Key Indicators

Market Cap
$18.42M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.09
Revenue (TTM)
$4.45B
Return On Equity (TTM)
-137.31%
Profit Margin
-84.94%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
6.82%

Biomerica Quarterly Profit & Loss

All figures in USD

ParticularsNov 2025Feb 2026May 2026Aug 2026
Revenue$1.21$0.99$0.88$1.27
Net Profit-$1.32-$1.31-$1.15-$1.23
Net Profit Margin-109.09%-132.32%-130.68%-96.85%
Income ChangeN/A0.76%12.21%-6.96%

Biomerica Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$5.47$5.42$5.31$4.45
Net Profit-$7.14-$5.98-$4.97-$3.78
Net Profit Margin-130.53%-110.33%-93.60%-84.94%
Income ChangeN/A16.25%16.89%23.94%

Biomerica Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets2.741.071.521.66
Current Assets4.024.887.7312.8
Total Assets6.765.959.2514.45
Non Current Liabilities1.650.10.460.79
Current Liabilities2.481.742.21.95
Total Liabilities4.131.842.662.73
Shareholders' Equity2.634.116.5911.72

Biomerica Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-3.42-3.84-5.36-5.47
Investing0.0-0.04-0.12-0.08
Financing2.332.11-0.089.39

Corporate Actions

Split
Ex-date: 21 Apr 2025

About Biomerica

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.

Biomerica Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.73
$1.09
-35.40%
Oct 2026
$2.05
$1.70
-26.78%
Sep 2026
$2.15
$2.31
+12.65%
Aug 2026
$1.60
$2.06
+23.80%
Jul 2026
$1.68
$1.66
-6.48%
Jun 2026
$2.22
$1.77
-27.25%
May 2026
$2.18
$2.44
+10.91%
Apr 2026
$2.18
$2.20
+9.51%
Mar 2026
$2.04
$2.01
-3.41%
Feb 2026
$2.40
$2.08
-12.61%
Jan 2026
$2.55
$2.38
-4.80%
Dec 2025
$2.31
$2.50
+6.84%

Biomerica Share Price FAQs